J&J talc claimants urge judge to reject $8B settlement, bankruptcy plan

Justin Sullivan
A group of claimants who say they developed cancer by using Johnson & Johnson (NYSE:JNJ) talc-based products have asked a judge to reject the healthcare giant’s plan to settle lawsuits for ~$8B as part of a bankruptcy plan.
Lawyers for